"Vaccination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
Descriptor ID |
D014611
|
MeSH Number(s) |
E02.095.465.425.400.530.890 E05.478.550.600.890 N02.421.726.758.310.890 N06.850.780.200.425.900 N06.850.780.680.310.890
|
Concept/Terms |
Immunization, Active- Immunization, Active
- Active Immunization
- Active Immunizations
- Immunizations, Active
|
Below are MeSH descriptors whose meaning is more general than "Vaccination".
Below are MeSH descriptors whose meaning is more specific than "Vaccination".
This graph shows the total number of publications written about "Vaccination" by people in this website by year, and whether "Vaccination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1995 | 0 | 3 | 3 |
1996 | 3 | 8 | 11 |
1997 | 1 | 2 | 3 |
1998 | 4 | 4 | 8 |
1999 | 3 | 7 | 10 |
2000 | 7 | 7 | 14 |
2001 | 3 | 7 | 10 |
2002 | 6 | 8 | 14 |
2003 | 3 | 13 | 16 |
2004 | 1 | 12 | 13 |
2005 | 3 | 11 | 14 |
2006 | 12 | 7 | 19 |
2007 | 7 | 9 | 16 |
2008 | 5 | 6 | 11 |
2009 | 7 | 12 | 19 |
2010 | 4 | 10 | 14 |
2011 | 11 | 18 | 29 |
2012 | 8 | 11 | 19 |
2013 | 9 | 9 | 18 |
2014 | 15 | 13 | 28 |
2015 | 8 | 10 | 18 |
2016 | 25 | 15 | 40 |
2017 | 21 | 18 | 39 |
2018 | 11 | 22 | 33 |
2019 | 13 | 35 | 48 |
2020 | 14 | 29 | 43 |
2021 | 21 | 49 | 70 |
2022 | 6 | 73 | 79 |
2023 | 2 | 58 | 60 |
2024 | 7 | 39 | 46 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccination" by people in Profiles.
-
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study. Emerg Microbes Infect. 2024 Dec; 13(1):2421397.
-
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023. Influenza Other Respir Viruses. 2024 Nov; 18(11):e70027.
-
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity. Sci Transl Med. 2024 Oct 23; 16(770):eadp8920.
-
Effects of religion, politics and distance to providers on HPV vaccine attitudes and intentions of parents in rural Utah. PLoS One. 2024; 19(10):e0312549.
-
Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19. Viruses. 2024 Oct 12; 16(10).
-
Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness. Sci Rep. 2024 09 13; 14(1):21466.
-
Human Papillomavirus Vaccination and Human Papillomavirus-Related Cancer Rates. JAMA Netw Open. 2024 Sep 03; 7(9):e2431807.
-
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases. Nat Commun. 2024 Aug 29; 15(1):7469.
-
Select Gut Microbiota Impede Rotavirus Vaccine Efficacy. Cell Mol Gastroenterol Hepatol. 2024; 18(5):101393.
-
What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective? J Infect Dis. 2024 Aug 16; 230(2):382-393.